About Gt Medical Technologies
Gt Medical Technologies is a private company based in Tempe, Arizona. It has reported $164,358,389 raised in seven offerings on Form D since December 2017. Its chief executive is Per Langoe.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 8, 2026 | Jul 22, 2026 | $50,056,676of $100.0M target | 39 | $1.2M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 23, 2024 | Mar 3, 2025amended Jun 11, 2025 | $53,300,905fully sold | 37 | $1.4M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 20, 2023 | Mar 24, 2023 | $37,420,783of $45.1M target | 33 | $1.1M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 13, 2020 | Nov 18, 2020 | $15,484,660of $16.0M target | 15 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Nov 14, 2018 | Nov 26, 2018 | $5,641,290of $10.0M target | 30 | $188K | EquityRule 506(b) | Form D ↗ |
| Dec 29, 2017 | Jan 5, 2018 | $1,944,075of $2.2M target | 4 | $486K | EquityRule 506(b) | Form D ↗ |
| Dec 6, 2017 | Dec 14, 2017 | $510,000of $750K target | 5 | $102K | DebtRule 506(b) | Form D ↗ |
| Total, seven offerings | $164,358,389 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Gt Medical Technologies's Form D filed Jul 22, 2026.
Earlier filings also listed Geoff Pardo (director, last listed Jun 2025), Camilo Rico (director, last listed Jun 2025), Adam Lessler (director, last listed Jun 2025), Radu Cautis (director, last listed Apr 2024), Matthew Likens (chief executive officer and director, last listed Mar 2023), Brian Martin (executive officer, last listed Nov 2020), Theresa Thomas (promoter, last listed Jan 2018) and Peter Nakaji (promoter, last listed Jan 2018).